Eyelash Treatment (LATISSE®)
Eyelash Growth Treatment
Have you always wanted longer, fuller, lusher eyelashes? Have your lashes grown thin or sparse with age? LATISSE® (bimatoprost ophthalmic solution) is an effective treatment. LATISSE® is not a temporary fix or a cosmetic illusion. It encourages the growth and thickening of your natural lashes for real results that last. LATISSE® is the only prescription treatment for eyelash growth that is approved by the United States Food & Drug Administration (FDA).
Get the facts about LATISSE®:
- LATISSE® is a once-a-day topical treatment, applied to the base of the upper eyelashes for results in as little as eight weeks and total results 12 to 16 weeks into treatment
- LATISSE® was developed by Allergan, a giant in the pharmaceutical eye care market backed by 60 years of experience and research
- LATISSE® is effective because of its ingredient, bimatoprost, and secures real and lasting results from the inside out
- LATISSE® produces noticeable, measurable results: thicker, fuller, darker lashes, with 78% of participants reporting significant eyelash increase by week 16 in a clinical study
- LATISSE® is not an over the counter drug; it is a prescription treatment, so talk to our Dallas / Fort Worth Metroplex ophthalmologists about whether or not this medication is a good fit for you
Speak with our Dallas / Fort Worth Metroplex Eye Doctors About LATISSE®
It’s important to discuss LATISSE® with your doctor and to carefully follow usage guidelines. In a clinical study, approximately four percent of participants reported itchy eyes and / or redness while using LATISSE®. While these side effects went away quickly and were not symptoms of any allergic reaction, it is important to remember that using LATISSE® requires patience. Only use the recommended amount, and don’t play “catch up” by doubling the dose if you miss a session. You also must only use sterile, FDA-approved LATISSE® applicators. Less common side effects have also been reported, including irritation, dryness, eyelid redness, hyperpigmentation, and potential increased brown iris pigmentation.